IN8bio has unveiled a new T cell engager (TCE) platform, marking its first major push into autoimmune disease. The biotech, which previously focused on oncology, introduced INB-619, a CD19-targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback